Table 3.
Results of Baseline Geriatric Assessment in 50 Subjects Evaluated for Allogeneic Hematopoietic Cell Transplantation
| Domain | Measure | Mean Score (±SD), Min – Max |
Number (%) with Abnormal Domain |
|---|---|---|---|
| Comorbidity | HCT-CI | 2.8 (±2), 0–7 | 29 (58) |
| Polypharmacy | Medication Number | 7.0 (±4.2), 1–17 | 14 (28) |
| Nutritional Status | MNA | 25 (±3.4), 11.5–30 | 18 (36) |
| Physical Performance | SPPB | 10.9 (±1.5), 6–12 | 9 (18) |
| Functional Status | ADL | 11.8 (±0.4), 10–12 | 8 (16) |
| IADL | 14.8 (±2.5), 9–16 | ||
| 7.9 (±0.4), 6–8 | |||
| Social Support | MOS | 89.9 (±7.5), 60–95 | 27 (54) |
| Psychological Status | HADS-Anxiety | 4.0 (±3.2), 0–13 | 5 (10) |
| HADS-Depression | 2.1 (±1.9), 0–10 | ||
| Cognition | CLOX 1 | 12.1 (±2.8), 2–15 | 8 (16) |
| CLOX 2 | 14.5 (±0.6), 13–15 | ||
| TMTA | 28.9 (±8.6), 15–54 | ||
| TMTB | 88.9 (±48.8), 23–253 |
Abbreviations: HCT-CI, Hematopoietic and Cellular Therapy-Comorbidity Index; MNA, Mini-Nutritional Assessment; SPPB, Short Physical Performance Battery; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MOS, Medical Outcomes Survey; HADS, Hospitalized Anxiety and Depression Scale; CLOX, Clock Draw Test; TMTA, Trail Making Test A; TMTB, Trail Making Test B